Inventiva (IVA) Beginning Cash Balance (2019 - 2025)
Inventiva (IVA) posted quarterly Beginning Cash Balance of $88.3 million for Q4 2022, down 26.96% year-over-year from $120.9 million in Q4 2021, and down 2.22% quarter-over-quarter from $90.3 million in Q3 2022.
Inventiva (IVA) Beginning Cash Balance (2019 - 2025) Analysis & Trends
Inventiva's Beginning Cash Balance history runs 4 years deep, the most recent figure standing at $88.3 million for Q4 2022.
- In Q4 2022, Beginning Cash Balance fell 26.96% year-over-year to $88.3 million; the TTM figure through Dec 2022 stood at $299.5 million (up 2.89% YoY), while the FY2022 annual figure was $88.3 million, down 26.96% from the prior year.
- Beginning Cash Balance for Q4 2022 stood at $88.3 million, down from $90.3 million in the prior quarter.
- The five-year high for Beginning Cash Balance was $127.5 million in Q1 2021, with the low at $39.6 million in Q1 2020.
- The 4-year median for Beginning Cash Balance is $88.3 million (2022), against an average of $81.7 million.
- The sharpest annual moves came in 2020 and 2021: Beginning Cash Balance sank 31.9% in 2020, then soared 222.21% in 2021.
- Inventiva's Beginning Cash Balance stood at $62.8 million in 2019, then slumped by 31.9% to $42.7 million in 2020, then surged by 182.94% to $120.9 million in 2021, then decreased by 26.96% to $88.3 million in 2022.
- Business Quant data shows IVA's Beginning Cash Balance at $88.3 million in Q4 2022, $90.3 million in Q3 2022, and $120.9 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 109.31 Mn |
| Jun 30, 2025 | 109.31 Mn |
| Jun 30, 2024 | 28.99 Mn |
| Jun 30, 2024 | 28.99 Mn |
| Jun 30, 2023 | 94.45 Mn |
| Jun 30, 2023 | 94.45 Mn |
| Dec 31, 2022 | 88.31 Mn |
| Dec 31, 2022 | 88.31 Mn |
| Sep 22, 2022 | 90.31 Mn |
| Sep 22, 2022 | 90.31 Mn |
| Dec 31, 2021 | 120.90 Mn |
| Dec 31, 2021 | 120.90 Mn |
| Mar 31, 2021 | 127.48 Mn |
| Mar 31, 2021 | 127.48 Mn |
| Dec 31, 2020 | 42.73 Mn |
| Dec 31, 2020 | 42.73 Mn |
| Mar 31, 2020 | 39.57 Mn |
| Mar 31, 2020 | 39.57 Mn |
| Dec 31, 2019 | 62.75 Mn |
| Dec 31, 2019 | 62.75 Mn |